Recent reports have confirmed that CD93 is overexpressed in glioblastoma (GBM) vasculature both in mRNA (Xie et al. 2021) and protein level compared with low-grade gliomas (LGG) and normal brain tissue (Lugano et al. 2018). This evidence concerns the gene CD93 and glioblastoma.